Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 436 | 1,693 | 1,633 | 2,638 | 2,420 |
| Gross Profit | 436 | 1,693 | 1,633 | 2,638 | 2,420 |
| Operating Expenses | 7,224 | 5,880 | 7,412 | 8,974 | 7,556 |
| Operating Income | -6,788 | -4,187 | -5,780 | -6,337 | -5,137 |
| Other Income | 2,643 | -4,078 | 292 | 1,780 | 2,299 |
| Pre-tax Income | -4,145 | -8,265 | -5,488 | -4,557 | -2,837 |
| Net Income Continuous | -4,145 | -8,265 | -5,488 | -4,557 | -2,837 |
| Minority Interests | -11 | -10 | -12 | -15 | -15 |
| Net Income | $-4,133 | $-8,255 | $-5,476 | $-4,542 | $-2,822 |
| EPS Basic Total Ops | -1.44 | -2.88 | -1.92 | -1.92 | -0.96 |
| EPS Basic Continuous Ops | -1.47 | -2.94 | -2.07 | -1.72 | -1.07 |
| EPS Diluted Total Ops | -1.44 | -2.88 | -1.92 | -1.92 | -0.96 |
| EPS Diluted Continuous Ops | -1.47 | -2.94 | -2.07 | -1.72 | -1.07 |
| EBITDA(a) | $-6,291 | $-3,689 | $-5,277 | $-5,835 | $-4,633 |